-
- Mar 27/28
New technology is poised to bring gene therapy to common chronic diseases - Mar 27/25
Gene editing with adeno-associated virus vector offers hope for hereditary deafness - Mar 27/25
Successful CAR-T cell therapy for end-stage multiple myeloma using advanced cellular product performed in Hong Kong - Mar 27/25
Beam Therapeutics reports gene editing breakthrough - Mar 27/25
Advancing gene therapy: How the industry is moving beyond the trough of disillusionment - Mar 27/25
Elusive stem cells discovered in human retina may lead to treatment for blindness - Mar 27/25
Correcting the mutation behind a genetic eye disease - Mar 26/25
New protein target identified for muscle repair and regeneration - Mar 26/25
Epicrispr banks $68M to test epigenetic editing on rare muscle disease - Mar 26/25
Real-world study suggests DMD gene therapy Is safe, effective - Mar 26/25
User-friendly software enables easy estimation of 3D gene expression distribution - Mar 26/25
Cell connections: Overcoming barriers in stem cell communication via mRNA transfer - Mar 26/25
How inherited cancer risks can be used for effective personalized therapy - Mar 26/25
New method may serve as platform for creating cell therapies for ALS - Mar 26/25
Cedars-Sinai study shows rapid healing of heart damage with cell therapy - Mar 25/25
Glucose revealed as a master regulator of tissue regeneration in Stanford Medicine study - Mar 25/25
Celestial cells: Advancing regenerative heart therapies in space - Mar 25/25
New technology is poised to bring gene therapy to common chronic diseases - Mar 25/25
Armouring up CAR T cells to fight solid tumours - Mar 25/25
Ethically sourced “spare” human bodies could revolutionize medicine - Mar 25/25
Impatient about cell and gene therapy? Progress in biotech is not always linear - Mar 24/25
Verve gets FDA green light to expand base editing trial into U.S. - Mar 24/25
Halting the march of ‘zombie cells’: Platform paves the way for new treatments against age-related diseases - Mar 24/25
Paralyzed man stands again after receiving ‘reprogrammed’ stem cells - Mar 24/25
Doubling adult stem cells outside the body for bone marrow regeneration - Mar 23/25
Weekly reads: Chinese CRISPR biotechs, cultured meat war, MSCs for Alzheimer’s - Mar 22/25
Japanese scientists use stem cell treatment to restore movement in spinal injury patients - Mar 22/25
Study reveals key role of Treg cells in preventing autoimmune responses - Mar 21/25
Nursery of the blood: How stem cells calm the body’s immune response - Mar 21/25
Europe’s largest biotech fund exceeds target with €165m - Mar 20/25
Yale scientists develop advanced CRISPR tool to study complex genetic interactions - Mar 20/25
Revolutionary CRISPR technology offers enhanced precision for gene editing and optimized disease models - Mar 20/25
Regulatory T-cell therapy calms autoimmune response from gluten-sensitive T cells in mice - Mar 20/25
Can tissue engineering and regenerative medicine reverse spinal cord injuries? - Mar 20/25
2025 Killam Prizes awarded to Drs. Marco Marra and Peter Zandstra - Mar 20/25
Novartis reports Phase III efficacy and safety outcomes of SMA treatment - Mar 19/25
Breakthrough study unveils mechanics of DNA unwinding - Mar 19/25
Allogeneic cell therapies “poised for prime time” says expert - Mar 19/25
Cell therapy biotech Century Therapeutics axes cancer trial, turns to autoimmune - Mar 19/25
Manufacturing magic: Takeda and Autolus spill the beans on cell therapy production - Mar 18/25
Novel lentiviral vector advances gene therapy for rare neurological disease - Mar 18/25
Unique 3D printed bioresorbable implants for patient-specific bone repair - Mar 18/25
Arbor sails into rocky gene editing waters with $74M for rare liver disease therapy - Mar 18/25
CRISPR targets key cancer gene in Ewing sarcoma - Mar 18/25
Sarepta says teen died after its gene therapy treatment - Mar 17/25
BioSurfaces collaborates with Morphocell for innovation - Mar 17/25
Scientists gain insight into RNA-editing protein that could lead to improved treatment for cancer, autoimmune diseases - Mar 17/25
Cellular showdown: The battle for dominance in neighbourhood disputes - Mar 17/25
AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal - Mar 15/25
Can we reverse aging? Scientists uncover a key “zombie cell” pathway - Mar 13/25
MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup - Mar 13/25
Resurrected ancient enzyme could transform gene editing - Mar 13/25
CAR T-cell therapy cuts costs, reduces treatment in mantle cell lymphoma - Mar 13/25
European regulators warn about dangers of unregulated cell therapies - Mar 13/25
MIT engineers turn skin cells directly into neurons for cell therapy
- Mar 27/28
